Scarica l'app Stockscreener
18.98
3.66%
0.67
Dopo l'orario di chiusura:
19.00
0.02
+0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SMMT Giù?
Forum
Previsione
Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
18.99%
0.213
|
0.179 | 0.265 | -0.027 | 0.584 |
Operating Expenses
|
17.07%
42.60
|
36.39 | 20.76 | 15.77 | 537.74 |
| Benefits Costs and Expenses |
18.89%
43.69
|
36.75 | 21.53 | 14.69 | 542.96 |
| Costs And Expenses |
17.07%
42.60
|
36.39 | 20.76 | 15.77 | 537.74 |
| Operating Income/Loss |
17.06%
-42.39
|
-36.21 | -20.49 | -15.79 | -537.15 |
| Nonoperating Income/Loss |
203.64%
-1.084
|
-0.357 | -0.776 | 1.077 | -5.222 |
| Income/Loss From Continuing Operations Before Tax |
18.89%
-43.47
|
-36.57 | -21.27 | -14.72 | -542.38 |
| Income/Loss From Continuing Operations After Tax |
18.89%
-43.47
|
-36.57 | -21.27 | -14.72 | -542.38 |
|
Net Income/Loss
|
18.89%
-43.47
|
-36.57 | -21.27 | -14.72 | -542.38 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,473%
701.79
|
27.28 | 697.74 | 697.69 | 378.16 |
| Diluted Average Shares |
2,473%
701.79
|
27.28 | 697.74 | 697.69 | 378.16 |
| Basic Earnings Per Share |
500.00%
-0.06
|
-0.01 | -0.03 | -0.02 | -1.43 |
| Diluted Earnings Per Share |
500.00%
-0.06
|
-0.01 | -0.03 | -0.02 | -1.43 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.45%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):